Literature DB >> 27993844

Comparison of four alternative national universal anterior cruciate ligament injury prevention programme implementation strategies to reduce secondary future medical costs.

Dion A Lewis1, Brent Kirkbride2,3, Christopher J Vertullo1,4, Louisa Gordon5, Tracy A Comans3,6.   

Abstract

BACKGROUND/AIM: Anterior cruciate ligament (ACL) injury is a common and devastating sporting injury. With or without ACL reconstruction, the risk of knee osteoarthritis (OA) and permanent disability later in life is markedly increased. While neuromuscular training programmes can prevent 50-80% of ACL injuries, no national implementation strategies exist in Australia. The aim of this study was to compare the ability of four alternative national universal ACL injury prevention programme implementation strategies to reduce future medical costs secondary to ACL injury.
METHODS: A Markov economic decision model was constructed to estimate the value in lifetime future medical costs prevented by implementing a national ACL prevention programme among four hypothetical cohorts: high-risk sport participants (HR) aged 12-25 years; HR 18-25 years; HR 12-17 years; all youths (ALL) 12-17 years.
RESULTS: Of the four programmes examined, the HR 12-25 programme provided the greatest value, averting US$693 of direct healthcare costs per person per lifetime or US$221 870 880 in total. Without training, 9.4% of this cohort will rupture their ACL and 16.8% will develop knee OA. Training prevents 3764 lifetime ACL ruptures per 100 000 individuals, a 40% reduction in ACL injuries. 842 lifetime cases of OA per 100 000 individuals and 584 TKRs per 100 000 are subsequently averted. Numbers needed to treat ranged from 27 for the HR 12-25 to 190 for the ALL 12-17.
CONCLUSIONS: The HR 12-25 programme was the most effective implementation strategy. Estimation of the break-even cost of health expenditure savings will enable optimal future programme design, implementation and expenditure. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Anterior cruciate ligament; Injury prevention; Neuromuscular; Osteoarthritis; Public health

Mesh:

Year:  2016        PMID: 27993844     DOI: 10.1136/bjsports-2016-096667

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  6 in total

1.  Trends in Pediatric and Adolescent Anterior Cruciate Ligament Injuries in Victoria, Australia 2005-2015.

Authors:  Louise Shaw; Caroline F Finch
Journal:  Int J Environ Res Public Health       Date:  2017-06-05       Impact factor: 3.390

2.  Osteoarthritis action alliance consensus opinion - best practice features of anterior cruciate ligament and lower limb injury prevention programs.

Authors:  Thomas Trojian; Jeffrey Driban; Rathna Nuti; Lindsay Distefano; Hayley Root; Cristina Nistler; Cynthia LaBella
Journal:  World J Orthop       Date:  2017-09-18

3.  Trends in Australian knee injury rates: An epidemiological analysis of 228,344 knee injuries over 20 years.

Authors:  Nirav Maniar; Evert Verhagen; Adam Leigh Bryant; David Andrew Opar
Journal:  Lancet Reg Health West Pac       Date:  2022-03-22

Review 4.  Prevention of Non-Contact Anterior Cruciate Ligament Injuries among Youth Female Athletes: An Umbrella Review.

Authors:  Anmol T Mattu; Brianna Ghali; Vanessa Linton; Alex Zheng; Ian Pike
Journal:  Int J Environ Res Public Health       Date:  2022-04-12       Impact factor: 4.614

5.  Exosomes derived from magnetically actuated bone mesenchymal stem cells promote tendon-bone healing through the miR-21-5p/SMAD7 pathway.

Authors:  Xiang-Dong Wu; Lin Kang; Jingjing Tian; Yuanhao Wu; Yue Huang; Jieying Liu; Hai Wang; Guixing Qiu; Zhihong Wu
Journal:  Mater Today Bio       Date:  2022-06-11

Review 6.  Health Economic Evaluations of Hip and Knee Interventions in Orthopaedic Sports Medicine: A Systematic Review and Quality Assessment.

Authors:  Codie A Primeau; Bryn O Zomar; Lyndsay E Somerville; Ishita Joshi; J Robert Giffin; Jacquelyn D Marsh
Journal:  Orthop J Sports Med       Date:  2021-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.